Physician profile
Jon Stoppel
NPI 1114118882
$3,076.84
in general payments reported to CMS, 2019-2025
19 companies · $540 in 2025
The $540 reported for 2025 was more than what 79% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $479 · 2020: $472 · 2021: $408 · 2022: $507 · 2023: $279 · 2024: $393 · 2025: $540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,211.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $842.92 | 2022-2025 | Vyzulta, Miebo, Infuse |
| Sun Pharmaceutical Industries INC. | $294.42 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $291.72 | 2019-2020 | |
| Allergan, INC. | $261.53 | 2019-2022 | |
| Johnson & Johnson Vision Care, INC. | $245.76 | 2020-2025 | Acuvue |
| Coopervision INC. | $147.97 | 2019-2023 | Myday Contact Lens |
| Rxsight INC | $122.53 | 2022 | |
| Dompe US, INC. | $119.60 | 2025 | Oxervate |
| Aerie Pharmaceuticals, INC. | $113.02 | 2021 | |
| Oyster Point Pharma, INC. | $97.82 | 2022-2023 | Tyrvaya |
| Abb Con-Cise Optical Group LLC | $97.55 | 2019-2024 | Spectacle Lenses, Contact Lens |
| Genzyme Corporation | $83.93 | 2019 | |
| Novartis Pharmaceuticals Corporation | $81.60 | 2021-2022 | |
| Sight Sciences, INC. | $79.94 | 2020 | |
| Harrow Eye, LLC | $65.77 | 2024 | Flarex, Tobradex St, Ilevro |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $58.39 | 2025 | Xdemvy |
| Alcon Vision LLC | $32.66 | 2021-2025 | Precision7 |
| Ani Pharmaceuticals, INC. | $22.54 | 2024 | Purified Cortrophin Gel |
| Carl Zeiss Meditec USA, INC. | $17.17 | 2024 | Cirrus Hd-Oct |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Stoppel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.